Clinical testing underway utilizing matched samples from ALCMI’s Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Trial Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015 Novel biofluid-based diagnostics offer the potential to ...
Read More »